Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
0.591
-0.031 (-5.03%)
Nov 21, 2024, 10:06 AM EST - Market open
Protagenic Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 1.22 | 1.21 | 1.97 | 3 | 1.85 | 1.28 | |
| Research & Development | 4.05 | 3.32 | 1.59 | 1.14 | 0.7 | 0.81 | |
| Operating Expenses | 5.27 | 4.53 | 3.56 | 4.14 | 2.55 | 2.09 | |
| Operating Income | -5.27 | -4.53 | -3.56 | -4.14 | -2.55 | -2.09 | |
| Interest Expense | -0.01 | -0.11 | -0.14 | -0.5 | -0.25 | -0.02 | |
| Interest & Investment Income | 0.09 | 0.26 | 0.19 | 0.03 | 0 | 0 | |
| Other Non Operating Income (Expenses) | - | - | - | 0.08 | 0.25 | 0.34 | |
| EBT Excluding Unusual Items | -5.19 | -4.37 | -3.51 | -4.52 | -2.55 | -1.76 | |
| Gain (Loss) on Sale of Investments | -0.43 | -0.63 | -0.05 | -0 | - | 0 | |
| Pretax Income | -5.65 | -5 | -3.56 | -4.52 | -2.55 | -1.75 | |
| Net Income | -5.65 | -5 | -3.56 | -4.52 | -2.55 | -1.75 | |
| Net Income to Common | -5.65 | -5 | -3.56 | -4.52 | -2.55 | -1.75 | |
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 3 | 3 | |
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 3 | 3 | |
| Shares Change (YoY) | 2.87% | 0.62% | 17.17% | 42.57% | 0.76% | - | |
| EPS (Basic) | -1.27 | -1.15 | -0.82 | -1.23 | -0.99 | -0.68 | |
| EPS (Diluted) | -1.27 | -1.15 | -0.82 | -1.23 | -0.99 | -0.68 | |
| Free Cash Flow | -4.64 | -3.85 | -2 | -2.8 | -1.35 | -0.49 | |
| Free Cash Flow Per Share | -1.04 | -0.89 | -0.46 | -0.76 | -0.52 | -0.19 | |
| EBITDA | -5.21 | -4.5 | -3.56 | -4.14 | -2.55 | -2.09 | |
| D&A For EBITDA | 0.06 | 0.03 | 0 | 0 | 0 | 0 | |
| EBIT | -5.27 | -4.53 | -3.56 | -4.14 | -2.55 | -2.09 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.